Patent application number | Description | Published |
20100124509 | RECIPROCATING GAS COMPRESSOR WITH SPEED MODULATION OF COMPRESSOR DRIVER FOR PULSATION AVOIDANCE - A method for reducing pulsation in a gas compressor system. The compressor driver (engine or motor) is operated at a modulated engine speed. The average of the modulated speed is selected to achieve a desired pipeline flow. The modulation characteristics are determined to optimally reduce the pulsation response of the compressor system. | 05-20-2010 |
20110023980 | PROGRAMMABLE DEVICE FOR COMPRESSOR VALVE - An electronic, programmable device for controlling the motion of compressor valve elements, wherein the device receives an incoming signal from a velocity sensor located on a compressor valve; filters, amplifies, and processes the incoming signal by a control algorithm; and responds to the incoming signal by creating an output signal that produces an actuator force that is applied directly to a moving valve element and associated methodology. | 02-03-2011 |
20110243760 | Pressure Recovery Insert for Reciprocating Gas Compressor - A method of reducing pulsations in a reciprocating compressor system, the system having nozzles between cylinders and filter bottles of the compressor system, the nozzles attaching at ports of the cylinders and filter bottles. A special insert is designed to be placed in one or more of the nozzle. The insert is generally cylindrical, but has a narrowed throat, a flared inlet end, and a flared outlet end. The insert dimensions, such as the inner diameter of the throat and the distance from the throat to the outlet end are calculated to reduce pulsations as well as provide pressure recovery. | 10-06-2011 |
20110277457 | Energy Storage and Production Systems, Apparatus and Methods Of Use Thereof - Systems, apparatus and methods of compressed air energy storage and electrical power generation are provided. In one embodiment, an apparatus is provided having a magnetic piston within a cylinder and an air chamber at each end of the piston; an electromagnetic coil is operable with the piston to convert an input of electrical power to a first reciprocating movement of the piston sufficient to generate compressed air in the chambers for storage in a compressed air storage reservoir; and the electromagnetic coil is operable with the piston to convert a second reciprocating movement of the piston to an output of electrical power connectable to a power grid, with the second reciprocating movement of the piston generated by bursts of the compressed air from the storage reservoir introduced into the chambers. | 11-17-2011 |
20120090352 | Methods And Apparatus For An Oxy-Fuel Based Power Cycle - Methods and apparatus for an oxy-fuel combustion power cycle are provided, including converting gaseous carbon dioxide to liquid and/or supercritical carbon dioxide which may include the use of a cryogenic pump, removing a portion of the liquid and/or supercritical carbon dioxide from the cycle, combusting oxygen and a combustion fuel with the remaining liquid and/or supercritical carbon dioxide in an oxy-fuel combustor to generate steam and additional liquid and/or supercritical carbon dioxide which replaces the portion of the liquid and/or supercritical carbon dioxide sequestered from the cycle. | 04-19-2012 |
Patent application number | Description | Published |
20090214845 | PROCESS OF PRODUCING A CERAMIC MATRIX COMPOSITE ARTICLE AND ARTICLE FORMED THEREBY - A CMC article and process for producing the article to have a layer on its surface that protects a reinforcement material within the article from damage. The method entails providing a body containing a ceramic reinforcement material in a matrix material that contains a precursor of a ceramic matrix material. A fraction of the reinforcement material is present and possibly exposed at a surface of the body. The body surface is then provided with a surface layer formed of a slurry containing a particulate material but lacking the reinforcement material of the body. The body and surface layer are heated to form the article by converting the precursor within the body to form the ceramic matrix material in which the reinforcement material is contained, and by converting the surface layer to form the protective layer that covers any fraction of the reinforcement material exposed at the body surface. | 08-27-2009 |
20100027105 | ROBUST WINDOW FOR INFRARED ENERGY - Articles transparent to infrared radiation and resistant to impact and wear are provided. In one embodiment the article comprises a substrate and a composite coating disposed over the substrate and extending from an interface with the substrate to an external surface. The coating and the substrate are capable of transmitting infrared radiation. The composite coating comprises a first phase and a second phase, where the second phase has a higher resistance to erosive wear than the first phase. The coating comprises a compositional gradient proceeding from a first composition at the interface of the coating with the substrate to a second composition at the external surface, the first composition comprising a higher concentration of the first phase than that of the second composition. The first phase has at least one property selected from the group consisting of a) a coefficient of thermal expansion (CTE) that is within about plus or minus 3 parts per million per degree centigrade of a CTE of the substrate, and b) an index of refraction that is within a range from as high as about 0.1 plus the index of refraction of the substrate to as low as about the square root of the index of refraction of the substrate. | 02-04-2010 |
20100096066 | MEMBRANE STRUCTURE AND METHOD OF MAKING - A membrane structure is provided. A membrane structure has a top surface and a bottom surface. The membrane structure includes a plurality of sintered layers including an inner layer disposed between two outer layers. The membrane structure further includes a nonmonotonic gradient in pore size extending between the top surface and the bottom surface. A method of making a membrane structure is provided. The method includes the steps of providing at least one inner layer; providing a plurality of outer layers; and laminating the inner layer and the outer layers to obtain a membrane structure. | 04-22-2010 |
20100111803 | HIGH STRENGTH, FINE GRAINED SPINEL FOR WINDOW APPLICATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME - Disclosed herein is a spinel article. The article comprises a spinel material, wherein the spinel material has a monomodal grain size distribution with average grain sizes of less than or equal to about 15 micrometers, and a biaxial flexural strength of greater than or equal to about 300 megapascals when measured by a ring-on-ring flexural test as per ASTM Standard C1499-08. Disclosed herein too is a spinel article manufactured by a method comprising calcining a spinel powder; milling the powder in a milling medium; granulating the powder; screening the powder to a mesh size of about 40 to about 200 mesh; pressing the powder to form an article; burning out organics from the article; sintering the article; and hot isostatically pressing the article. | 05-06-2010 |
20100155252 | MEMBRANE STRUCTURE AND METHOD OF MAKING - A membrane structure is provided. The membrane structure includes a first layer having a plurality of interconnected pores; and a second layer disposed on the first layer. The second layer has a plurality of unconnected pores. Each of the unconnected pores is in fluid communication with at least one of the interconnected pores of the first layer. A method of making a membrane structure is provided. The method includes the steps of providing a first layer having a plurality of interconnected pores; and disposing a second layer on the first layer. Disposing a second layer includes depositing a conducting layer on the first layer; and anodizing the conducting layer to convert the conducting layer into a porous layer. | 06-24-2010 |
20110171399 | PROCESS AND APPARATUS FOR CONTINUOUS COATING OF FIBROUS MATERIALS - A process and apparatus for continuously depositing a coating on a fibrous material. The process is a chemical vapor deposition process that includes causing multiple strands of a fibrous material to continuously travel through a coating zone within an enclosed chamber defined by a housing so that portions of the strands contact a reactant gas as the portions travel through the chamber, directly heating the portions of the strands without physically contacting the strands and without directly heating the housing, and depositing a coating material on the strands as a result of the reactant gas contacting the portions of the strands and decomposing to form a coating of the coating material. Heating of the strands can be achieved by capacitive coupling, inductive coupling, microwave radiation, and radiant heating. | 07-14-2011 |
20130234374 | HIGH STRENGTH, FINE GRAINED SPINEL FOR WINDOW APPLICATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME - Disclosed herein is a spinel article. The article includes a spinel material, wherein the spinel material has a monomodal grain size distribution with average grain sizes of less than or equal to about 15 micrometers, and a biaxial flexural strength of greater than or equal to about 300 megapascals when measured by a ring-on-ring flexural test as per ASTM Standard C1499-08. Disclosed herein too is a method for manufacturing a spinel article, including calcining a spinel powder; milling the powder in a milling medium; granulating the powder; screening the powder to a mesh size of about 40 to about 200 mesh; pressing the powder to form an article; burning out organics from the article; sintering the article; and hot isostatically pressing the article. | 09-12-2013 |
20140272344 | COMPOSITE COATINGS AND METHODS THEREFOR - An article includes a substrate and a coating provided on a surface of the substrate. The coating includes at least one metal silicide layer consisting essentially of MoSi | 09-18-2014 |
Patent application number | Description | Published |
20110096076 | APPLICATION PROGRAM INTERFACE FOR ANIMATION - Many computer applications incorporate and support animation. Application performance may be enhanced by delegating animation management to an application program interface (animation API) for animation. Accordingly, an animation API for managing animation is disclosed herein. The animation API may be configured to sequentially interpolate values of animation variables defining animation movement of animation objects. The animation API may interpolate the values of the animation variables using animation transitions within animation storyboards. The animation API may be configured to determine durations of animation transitions based upon animation characteristics parameters (e.g., starting position, desiring ending position, starting velocity of an animation variable). Durations and start times of animation transitions may be determined based upon key frames. The animation API may be configured to resolve scheduling conflicts among one or more animation transitions. Also, the animation API may be configured to facilitate smooth animation while switching between animation transitions for an animation variable. | 04-28-2011 |
20120150885 | CHANGE NOTIFICATIONS FROM AN UPDATED DATA REPRESENTATION - An original representation of an original set of data in a data source can be provided, and an updated representation of an updated set of data in the data source can be received. A change notification set that includes change notifications can be generated by comparing the updated representation with the original representation. The change notification set can represent a possible set of changes that yield the updated representation when starting with the original representation. The change notification set can be sent to a client of the data source. One or more requests from the client for data from the data source may be processed while obtaining the updated representation of the updated set of data. This processing can include adding one or more placeholders and matching the placeholder(s) with one or more items in the updated set of data. | 06-14-2012 |
20120150886 | PLACEHOLDERS RETURNED FOR DATA REPRESENTATION ITEMS - One or more requests from a client for data representation items can be received by an items manager. The data representation items can represent data items in a data source. In response, the items manager can perform the following: generating placeholders corresponding to the data representation items; returning the placeholders to the client; fetching the data items from the data source; providing the data representation items to the client; and informing the client that the placeholders are to be replaced with the data representation items. The items manager may determine whether each data representation item can be synchronously returned to the client. If so, the items manager may return that data representation item synchronously, and may forego providing the client with a placeholder for that data representation item. This may allow a client to interact with a single interface for both synchronous and asynchronous data sources. | 06-14-2012 |
20120191747 | DATA ITEMS MANAGER - An items manager can request and receive data items from a data source via a data source adapter. The items manager can also maintain a list of data representation items representing data items. The data representation items can include user interface elements. Also, maintaining the list can include invoking a renderer to render the data representation items from the data items received from the data source, and including the data representation items in the list. The items manager can provide a client with an enumeration through the list of data representation items. The items manager may also provide other features, such as providing the client with notifications of changes to the list of data representation items. | 07-26-2012 |
20120296875 | OPTIMISTIC APPLICATION OF DATA EDITS - A data representation that represents source data at a data source can be maintained. A request to perform an edit can be received from a client, and a request to make the edit to the source data can be sent to the data source. The edit can be optimistically applied to the data representation. Additionally, a change notification can be sent to the client. The change notification can indicate one or more changes to the data representation, where the change(s) resulted from the application of the edit to the data representation. A notification can be received from the data source after applying the edit to the data representation and after sending the change notification. The notification from the data source can indicate whether the edit to the source data succeeded. | 11-22-2012 |
20130179904 | ASYNCHRONOUS HANDLING OF AN INPUT STREAM DEDICATED TO MULTIPLE TARGETS - An operating system has a stack of input events (an input stack) that provides input events from various input devices to applications. A dedicated thread or other entity is provided to handle input events that are related to pixel manipulation on the display, so as to provide a highly responsive display. The thread includes a buffer, and manages the buffer so as to ensure that messages a received by an application or other entity in chronological order. | 07-11-2013 |
20140317538 | USER INTERFACE RESPONSE TO AN ASYNCHRONOUS MANIPULATION - In one embodiment, a graphical display device may synchronize movement between a primary content set 204 and a reflex content set 206 to create a parallax effect in a graphical user interface 202. The graphical display device may detect a user input indicating a primary position change 206 of a primary content set 204 in a graphical user interface 202. The graphical display device may instantiate a delegate thread to control a reflex content set 208. The graphical display device cause a reflex content set 208 to move in a controlled independent action 210 based on the primary position change 206. | 10-23-2014 |
20140375572 | PARAMETRIC MOTION CURVES AND MANIPULABLE CONTENT - Motion of manipulable content in response to input, such as touch input from a user can be defined by criteria set forth by parametric equations. An application that generates manipulable content can be tailored so that the manipulable content responds in a particular way to the input. A programmer can perform such tailoring by providing parametric equations as input to the application. A set of parametric equations can be applied to an input transform to generate an output transform, which can be used to affect motion of manipulable content as represented on an associated display, such as a touch screen display. | 12-25-2014 |
Patent application number | Description | Published |
20100058363 | Intent-Oriented User Interface Application Programming Interface - In accordance with one or more aspects of the intent-oriented user interface Application Programming Interface, a user interface platform includes an Application Programming Interface (API). An indication of multiple commands to be exposed for an application via a user interface is received from the application. For each of the multiple commands, a manner of display of a control corresponding to the command and a position for the control is determined on behalf of the application. Additionally, for each of the multiple commands the control corresponding to the command is displayed in accordance with the determined manner of display and the position for the control. The application is notified of user interactions with the user interface. | 03-04-2010 |
20120254780 | PREDICTIVE TILING - This document describes techniques and apparatuses for predictive tiling. These techniques predict tiles of content to pre-render so that an application will be ready to render content quickly in response to a user manipulation. By so doing, these techniques enable fast manipulation of content without unduly impacting drawing resources. | 10-04-2012 |
20120311488 | ASYNCHRONOUS HANDLING OF A USER INTERFACE MANIPULATION - This document describes techniques and apparatuses for asynchronous handling of a user interface manipulation. These techniques handle a user interface manipulation with two or more asynchronous processes. One asynchronous process, for example, may determine a position responsive to the user interface manipulation while another asynchronous process determines the pixels to render. By so doing, these techniques enable a quick and/or consistent response to a user interface manipulation. | 12-06-2012 |
20140137034 | ASYNCHRONOUS HANDLING OF A USER INTERFACE MANIPULATION - This document describes techniques and apparatuses for asynchronous handling of a user interface manipulation. These techniques handle a user interface manipulation with two or more asynchronous processes. One asynchronous process, for example, may determine a position responsive to the user interface manipulation while another asynchronous process determines the pixels to render. By so doing, these techniques enable a quick and/or consistent response to a user interface manipulation. | 05-15-2014 |
20140372923 | High Performance Touch Drag and Drop - High performance touch drag and drop are described. In embodiments, a multi-threaded architecture is implemented to include at least a manipulation thread and an independent hit test thread. The manipulation thread is configured to receive one or more messages associated with an input and send data associated with the messages to the independent hit test thread. The independent hit test thread is configured to perform an independent hit test to determine whether the input hit an element that is eligible for a particular action, and identify an interaction model associated with the input. The independent hit test thread also sends an indication of the interaction model to the manipulation thread to enable the manipulation thread to detect whether the particular action is triggered. | 12-18-2014 |
Patent application number | Description | Published |
20130072528 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. The therapies comprise administering Compound I (or a pharmaceutically acceptable salt thereof) and another anti-HCV agent. Preferably, the therapies are both interferon- and ribavirin-free. | 03-21-2013 |
20130102525 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 04-25-2013 |
20130102526 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 04-25-2013 |
20130102557 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 04-25-2013 |
20130102558 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 04-25-2013 |
20140024579 | METHODS FOR TREATING HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 01-23-2014 |
20140057835 | METHODS FOR TREATING HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 02-27-2014 |
20140107016 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 04-17-2014 |
20140107017 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 04-17-2014 |
20140323395 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 10-30-2014 |
20150024999 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 01-22-2015 |
20150025000 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. The therapies comprise administering 2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-exadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide (Compound I), or a pharmaceutically acceptable salt thereof, and another anti-HCV agent. Preferably, the therapies are both interferon- and ribavirin-free. The other anti-HCV agent can be a HCV polymerase inhibitor, an HCV NS5A inhibitor, an HCV entry inhibitor, a cyclophilin inhibitor, or an internal ribosome entry site inhibitor. Preferably, the other anti-HCV agent is an HCV polymerase inhibitor. Also preferably, the other anti-HCV agent is an HCV NS5A inhibitor. Also preferably, the other anti-HCV agent is administered concurrently with Compound I or a pharmaceutically acceptable salt thereof. In another example, the other anti-HCV agent is administered sequentially with Compound I or a pharmaceutically acceptable salt thereof. In still another embodiment, Compound I (or a pharmaceutically acceptable salt thereof) is co-administered with two or more other anti-HCV agents. For instance, Compound I (or a pharmaceutically acceptable salt thereof) can be co-administered with an HCV polymerase inhibitor and an HCV NS5A inhibitor. For another instance, Compound I (or a pharmaceutically acceptable salt thereof) can be co-administered with two different HCV polymerase inhibitors (e.g., one is a nucleoside polymerase inhibitor and the other is a non-nucleoside polymerase inhibitor; or both are nucleoside polymerase inhibitors; or both are non-nucleoside polymerase inhibitor). In yet another example, Compound I (or a pharmaceutically acceptable salt thereof) is co-administered with another HCV protease inhibitor and an HCV polymerase inhibitor. In still another example, Compound I (or a pharmaceutically acceptable salt thereof) is administered with two different HCV NS5A inhibitors. | 01-22-2015 |
Patent application number | Description | Published |
20130005889 | POLYARYLENE SULFIDE-CONTAINING POLYMER MELT - This invention relates to methods for decreasing the complex viscosity of a polyarylene sulfide polymer melt while maintaining the molecular weight of the polyarylene sulfide with time. This invention also relates to polymer melt compositions comprising a polyarylene sulfide, wherein the complex viscosity of the composition is decreased relative to the complex viscosity of the native polyarylene sulfide measured under the same conditions, and the weight average molecular weight of the polyarylene sulfide is maintained. The methods of decreasing the complex viscosity of a polyarylene sulfide-containing polymer melt, and the polymer melt compositions so obtained, are useful in processes to produce fibers, films, nonwovens, and molded parts from polyarylene sulfides. | 01-03-2013 |
20130005890 | THERMAL STABILIZATION OF POLYARYLENE SULFIDE COMPOSITIONS - Provided are novel compositions comprising a polyarylene sulfide and at least one tin additive comprising a branched tin(II) carboxylate selected from the group consisting of Sn(O | 01-03-2013 |
20130011544 | STABILIZATION OF POLYMERIC STRUCTURES - A method for stabilizing a polymeric structure against thermo-oxidative degradation is described. A polymeric core structure is provided with a skin layer that contains a skin resin in which the skin resin at least partially envelops a portion of the core structure. The skin structure then provides a barrier that thereby stabilizes the portion of the structure that is enveloped. The skin resin is made from a treated polyarylene sulfide. | 01-10-2013 |
20130012092 | STABILIZATION OF POLYMERIC STRUCTURES - A nonwoven web comprising bicomponent fibers. The fibers have continuous phases each of a first polyarylene sulfide (PAS) component and a polymer component. The polymer component may also be a second polyarylene sulfide. The first polyarylene sulfide component contains a tin or a zinc additive or both, and the first polyarylene sulfide component of any given fiber is at least partially exposed to the external surface of that fiber. | 01-10-2013 |
20130018135 | THERMOOXIDATIVE STABILIZATION OF POLYARYLENE SULFIDE COMPOSITIONS - Provided are novel compositions comprising a polyarylene sulfide and at least one tin additive comprising a branched tin(II) carboxylate selected from the group consisting of Sn(O | 01-17-2013 |
20130210307 | POLYARYLENE SULFIDE COMPOSITIONS - Provided are novel compositions comprising a polyarylene sulfide and at least one tin additive comprising a branched tin(II) carboxylate selected from the group consisting of Sn(O | 08-15-2013 |
20140087431 | GLUCOSYLTRANSFERASE ENZYMES FOR PRODUCTION OF GLUCAN POLYMERS - Reaction solutions are disclosed herein comprising water, sucrose and a glucosyltransferase enzyme that synthesizes poly alpha-1,3-glucan. The glucosyltransferase enzyme can synthesize insoluble glucan polymer having at least 50% alpha-1,3 glycosidic linkages and a number average degree of polymerization of at least 100. Further disclosed are methods of using such glucosyltransferase enzymes to produce insoluble poly alpha-1,3-glucan. | 03-27-2014 |